Valid for Submission
F15.181 is a billable diagnosis code used to specify a medical diagnosis of other stimulant abuse with stimulant-induced sexual dysfunction. The code F15.181 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code F15.181 are found in the index:
- - Abuse
- - Disorder (of) - See Also: Disease;
Diagnostic Related Groups - MS-DRG Mapping
Convert F15.181 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code F15.181 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
Also called: Substance abuse
Drug abuse is a serious public health problem that affects almost every community and family in some way. Each year drug abuse causes millions of serious illnesses or injuries among Americans. Abused drugs include
- Anabolic steroids
- Club drugs
- Prescription drugs, including opioids
Drug abuse also plays a role in many major social problems, such as drugged driving, violence, stress, and child abuse. Drug abuse can lead to homelessness, crime, and missed work or problems with keeping a job. It harms unborn babies and destroys families. There are different types of treatment for drug abuse. But the best is to prevent drug abuse in the first place.
NIH: National Institute on Drug Abuse
- Drug abuse (Medical Encyclopedia)
- Drug dependence (Medical Encyclopedia)
- Toxicology screen (Medical Encyclopedia)